Sales of Biological Safety Testing Market is Set to Increase at Under 10.0% CAGR by 2024

The biological safety testing market is a critical segment within the biotechnology and pharmaceutical industries. This market focuses on ensuring the safety and efficacy of biological products, such as vaccines, biopharmaceuticals, and cellular therapies. Regulatory authorities like the FDA and EMA emphasize rigorous safety standards, which drive the demand for biological safety testing services. These tests help identify potential contaminants, ensuring product quality and compliance with global regulations.

Market Size and Growth

From 2016 to 2024, the biological safety testing market witnessed robust growth, driven by the increasing adoption of biologics and biosimilars. The global market was valued at approximately US$ 1.31 billion in 2016 and was expected to grow at a CAGR of 10.0% during the forecast period, reaching US$3.08 bn  by 2024. Growth was propelled by advancements in biopharmaceutical research, stringent safety regulations, and the rising prevalence of chronic diseases requiring innovative biologic treatments.

𝐆𝐞𝐭 𝐚 𝐆𝐥𝐢𝐦𝐩𝐬𝐞 𝐈𝐧𝐬𝐢𝐝𝐞: 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐤𝐞𝐲 𝐟𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐚𝐧𝐝 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐟𝐫𝐨𝐦 𝐨𝐮𝐫 𝐑𝐞𝐩𝐨𝐫𝐭 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐬𝐚𝐦𝐩𝐥𝐞 - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18578

Market Segmentation

1. By Service Type
• Sterility Testing: Ensures the absence of viable contaminating microorganisms.
• Endotoxin Testing: Detects and quantifies bacterial endotoxins in biologics.
• Cell Line Authentication and Characterization: Verifies the identity and genetic stability of cell lines.
2. By Sourcing Type
• In-house Testing: Conducted by pharmaceutical companies within their facilities.
• Contract Outsourcing: Testing services provided by third-party organizations specializing in biological safety.
3. By Application
• Vaccine Development
• Gene and Cell Therapy
• Monoclonal Antibodies (mAbs)
• Blood and Blood Products
4. By Industry Vertical
• Biotechnology Companies
• Pharmaceutical Companies
• Academic and Research Institutes
5. By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Regional Analysis

• North America dominated the market in 2016, driven by a strong biotechnology sector and stringent regulatory frameworks.
• Europe followed, benefiting from advanced healthcare systems and robust R&D activities.
• Asia-Pacific emerged as the fastest-growing region, supported by increasing investments in biotechnology, a growing pharmaceutical sector, and favorable regulatory reforms.
• Latin America and Middle East & Africa demonstrated moderate growth due to improving healthcare infrastructure and rising awareness of biological safety.

𝐆𝐞𝐭 𝐀 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬: https://www.transparencymarketresearch.com/biological-safety-testing-market.html

Market Drivers and Challenges

Drivers

• Increasing Adoption of Biologics and Biosimilars: Rising prevalence of chronic diseases like cancer and autoimmune disorders drives demand for innovative biologics.
• Stringent Regulatory Frameworks: Compliance with safety regulations accelerates the adoption of safety testing services.
• Technological Advancements: Innovations in biological testing methods, including automation and rapid detection, enhance efficiency and accuracy.

Challenges

• High Costs of Testing: Advanced safety testing technologies and services often come at a premium, limiting accessibility.
• Complex Regulatory Compliance: Varying standards across regions create challenges for market players.

Market Trends

1. Automation in Testing: Adoption of robotic systems and AI to streamline biological safety testing processes.
2. Expansion of Contract Research Organizations (CROs): Growing outsourcing trend among biotech and pharma companies to reduce operational costs.
3. Increased Focus on Gene Therapy: Rising R&D investments in gene and cell therapies are spurring demand for advanced safety testing solutions.

Competitive Landscape

Key players in the biological safety testing market during this period included:

• Charles River Laboratories
• Lonza Group Ltd.
• Merck KGaA
• Sartorius AG
• Thermo Fisher Scientific

These companies focused on expanding their product portfolios, investing in R&D, and forming strategic partnerships to maintain competitive advantages.

Future Outlook

The biological safety testing market is poised for continued growth beyond 2024. Factors such as advancements in precision medicine, increasing adoption of biosimilars, and the growing emphasis on patient safety will likely sustain demand. Emerging economies are expected to play a significant role as their biotech sectors expand.

Key Market Study Points

• Accelerated adoption of sterility and endotoxin testing in vaccine production.
• Significant growth in outsourcing to CROs for cost-effective solutions.
• North America's leadership in market revenue due to advanced infrastructure.

Browse More Reports by TMR:

• Nucleic Acid Therapeutics Market : Projected to advance at a CAGR of 12.8% from 2024 to 2034 and reach more than US$ 22.1 Bn by the end of 2034
• Oxycodone Hydrochloride Market : expected to grow at a CAGR of 4.8% from 2024 to 2034 and reach US$ 675.2 Mn by the end of 2034

About Us:

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact Us:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453